In vitro antifungal activity of CAN-296: A naturally occurring complex carbohydrate

Avital Mazar Ben-Josef, Elias K. Manavathu, David Platt, Jack D. Sobel

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The in vitro activity of a naturally occurring complex carbohydrate, CAN-296, was evaluated by testing 132 clinical and ATCC isolates of yeast and Aspergillus fumigatus, many of which were azole-resistant. The in vitro susceptibility tests were performed by standardized broth micro-and macrodilution methods and results were compared with those obtained for amphotericin B, fluconazole, ketoconazole, flucytosine and the pneumocandin L-733,560. All tested Candida species showed highly uniform susceptibility to CAN-296 at concentrations of 0.078 to 0.312 μg/ml; non-albicans Candida were as susceptible to CAN-296 as the Candida albicans strains. Multi-azoleresistant Candida species were highly sensitive to CAN-296. Minimum inhibitory concentration measurements did not differ from minimum lethal concentrations by more than two-fold for all tested Candida species. Aspergillus fumigatus, on the other hand, showed only moderate susceptibility to CAN-296. The kinetics of the anti-Candida activity of CAN-296 was investigated by kill-curve experiments using C. albicans and C. glabrata and the results were compared with those obtain for amphotericin B. CAN-296 was found to be rapidly fungicidal in concentrations ranging from 4~16 fold the mean MIC value. The broad spectrum of anti-Candida activity together with the rapid fungicidal effect make this complex carbohydrate a promising agent for clinical use.

Original languageEnglish (US)
Pages (from-to)937-943
Number of pages7
JournalJournal of Antibiotics
Volume50
Issue number11
DOIs
StatePublished - Nov 1997

Fingerprint

Candida
Carbohydrates
Aspergillus fumigatus
Amphotericin B
Candida albicans
Flucytosine
Azoles
Ketoconazole
Fluconazole
Microbial Sensitivity Tests
CAN 296
In Vitro Techniques
Yeasts

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

In vitro antifungal activity of CAN-296 : A naturally occurring complex carbohydrate. / Ben-Josef, Avital Mazar; Manavathu, Elias K.; Platt, David; Sobel, Jack D.

In: Journal of Antibiotics, Vol. 50, No. 11, 11.1997, p. 937-943.

Research output: Contribution to journalArticle

Ben-Josef, Avital Mazar ; Manavathu, Elias K. ; Platt, David ; Sobel, Jack D. / In vitro antifungal activity of CAN-296 : A naturally occurring complex carbohydrate. In: Journal of Antibiotics. 1997 ; Vol. 50, No. 11. pp. 937-943.
@article{4eb54965ff4e40349ae379ff0fa363a1,
title = "In vitro antifungal activity of CAN-296: A naturally occurring complex carbohydrate",
abstract = "The in vitro activity of a naturally occurring complex carbohydrate, CAN-296, was evaluated by testing 132 clinical and ATCC isolates of yeast and Aspergillus fumigatus, many of which were azole-resistant. The in vitro susceptibility tests were performed by standardized broth micro-and macrodilution methods and results were compared with those obtained for amphotericin B, fluconazole, ketoconazole, flucytosine and the pneumocandin L-733,560. All tested Candida species showed highly uniform susceptibility to CAN-296 at concentrations of 0.078 to 0.312 μg/ml; non-albicans Candida were as susceptible to CAN-296 as the Candida albicans strains. Multi-azoleresistant Candida species were highly sensitive to CAN-296. Minimum inhibitory concentration measurements did not differ from minimum lethal concentrations by more than two-fold for all tested Candida species. Aspergillus fumigatus, on the other hand, showed only moderate susceptibility to CAN-296. The kinetics of the anti-Candida activity of CAN-296 was investigated by kill-curve experiments using C. albicans and C. glabrata and the results were compared with those obtain for amphotericin B. CAN-296 was found to be rapidly fungicidal in concentrations ranging from 4~16 fold the mean MIC value. The broad spectrum of anti-Candida activity together with the rapid fungicidal effect make this complex carbohydrate a promising agent for clinical use.",
author = "Ben-Josef, {Avital Mazar} and Manavathu, {Elias K.} and David Platt and Sobel, {Jack D.}",
year = "1997",
month = "11",
doi = "10.7164/antibiotics.50.937",
language = "English (US)",
volume = "50",
pages = "937--943",
journal = "Journal of Antibiotics",
issn = "0021-8820",
publisher = "Japan Antibiotics Research Association",
number = "11",

}

TY - JOUR

T1 - In vitro antifungal activity of CAN-296

T2 - A naturally occurring complex carbohydrate

AU - Ben-Josef, Avital Mazar

AU - Manavathu, Elias K.

AU - Platt, David

AU - Sobel, Jack D.

PY - 1997/11

Y1 - 1997/11

N2 - The in vitro activity of a naturally occurring complex carbohydrate, CAN-296, was evaluated by testing 132 clinical and ATCC isolates of yeast and Aspergillus fumigatus, many of which were azole-resistant. The in vitro susceptibility tests were performed by standardized broth micro-and macrodilution methods and results were compared with those obtained for amphotericin B, fluconazole, ketoconazole, flucytosine and the pneumocandin L-733,560. All tested Candida species showed highly uniform susceptibility to CAN-296 at concentrations of 0.078 to 0.312 μg/ml; non-albicans Candida were as susceptible to CAN-296 as the Candida albicans strains. Multi-azoleresistant Candida species were highly sensitive to CAN-296. Minimum inhibitory concentration measurements did not differ from minimum lethal concentrations by more than two-fold for all tested Candida species. Aspergillus fumigatus, on the other hand, showed only moderate susceptibility to CAN-296. The kinetics of the anti-Candida activity of CAN-296 was investigated by kill-curve experiments using C. albicans and C. glabrata and the results were compared with those obtain for amphotericin B. CAN-296 was found to be rapidly fungicidal in concentrations ranging from 4~16 fold the mean MIC value. The broad spectrum of anti-Candida activity together with the rapid fungicidal effect make this complex carbohydrate a promising agent for clinical use.

AB - The in vitro activity of a naturally occurring complex carbohydrate, CAN-296, was evaluated by testing 132 clinical and ATCC isolates of yeast and Aspergillus fumigatus, many of which were azole-resistant. The in vitro susceptibility tests were performed by standardized broth micro-and macrodilution methods and results were compared with those obtained for amphotericin B, fluconazole, ketoconazole, flucytosine and the pneumocandin L-733,560. All tested Candida species showed highly uniform susceptibility to CAN-296 at concentrations of 0.078 to 0.312 μg/ml; non-albicans Candida were as susceptible to CAN-296 as the Candida albicans strains. Multi-azoleresistant Candida species were highly sensitive to CAN-296. Minimum inhibitory concentration measurements did not differ from minimum lethal concentrations by more than two-fold for all tested Candida species. Aspergillus fumigatus, on the other hand, showed only moderate susceptibility to CAN-296. The kinetics of the anti-Candida activity of CAN-296 was investigated by kill-curve experiments using C. albicans and C. glabrata and the results were compared with those obtain for amphotericin B. CAN-296 was found to be rapidly fungicidal in concentrations ranging from 4~16 fold the mean MIC value. The broad spectrum of anti-Candida activity together with the rapid fungicidal effect make this complex carbohydrate a promising agent for clinical use.

UR - http://www.scopus.com/inward/record.url?scp=0031464022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031464022&partnerID=8YFLogxK

U2 - 10.7164/antibiotics.50.937

DO - 10.7164/antibiotics.50.937

M3 - Article

C2 - 9592567

AN - SCOPUS:0031464022

VL - 50

SP - 937

EP - 943

JO - Journal of Antibiotics

JF - Journal of Antibiotics

SN - 0021-8820

IS - 11

ER -